Vote Scores
Filings read through

Ventyx Biosciences, Inc.: how funds voted at the meeting of 3 Mar 2026

Meeting
Season
year to 30 June 2026
Filers reporting
154
Ballot items
3

154 filers on Form N-PX reported votes at the Ventyx Biosciences, Inc. meeting of 3 Mar 2026. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on pay tied to a merger or sale

    218 vote records from 154 filers. 14 of the 143 filers that marked the item voted against management. 11 filers gave no management mark.

    • Positions of 27 fund families
    • For 26
    • Against 1
    • Against management 1
  2. Item 2: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    59 vote records from 35 filers. 0 of the 35 filers that marked the item voted against management.

    • Positions of 15 fund families
    • For 15
  3. Item 3: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    75 vote records from 42 filers. 2 of the 42 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 16
    • Against 1
    • Against management 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Ventyx Biosciences, Inc., meeting of 3 Mar 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family1. Merger pay
American CenturyAgainst, against management
BlackRock and iSharesFor
BNY MellonFor
Charles SchwabFor
Columbia ThreadneedleFor
DimensionalFor
EquitableFor
Federated HermesFor
FidelityFor
Goldman SachsFor
InvescoFor
Jackson National fundsFor
Janus HendersonFor
John Hancock and ManulifeFor
Lincoln FinancialFor
Macquarie and Delaware FundsFor
MassMutualFor
Morgan Stanley, Eaton Vance and CalvertFor
Neuberger BermanFor
Northern Trust and FlexSharesFor
PGIM and PrudentialFor
PIMCOFor
ProShares and ProFundsFor
State Street and SPDRFor
T. Rowe PriceFor
VanguardFor
Victory CapitalFor

Questions

How many filers reported votes at the Ventyx Biosciences, Inc. meeting?
154 Form N-PX filers reported votes at the meeting of 3 Mar 2026.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Ventyx Biosciences, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Ventyx Biosciences, Inc. with a meeting date within three days of 3 Mar 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .